| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |